The present invention relates to a pharmaceutical composition comprising tiotropium a hydrofluoroalkane (HFA) propellant, and optionally one or more pharmaceutically acceptable excipients to a process for preparing such a pharmaceutical composition, and the use thereof in medicine, in particular for the prophylaxis and treatment of respiratory disorders.